Kyndryl (KD) Financials

$33.48 +0.33 (+1.00%)

As of 11:39 AM Eastern

Annual Income Statements for Kyndryl

This table shows Kyndryl's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	3/31/2023	3/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-943	-2,007	-2,304	-1,374	-340
Consolidated Net Income / (Loss)	-943	-2,007	-2,304	-1,374	-340
Net Income / (Loss) Continuing Operations	-943	-2,007	-2,305	-1,375	-340
Total Pre-Tax Income	-579	-1,760	-1,903	-851	-168
Total Operating Income	-503	-1,697	-1,800	-756	91
Total Gross Profit	2,597	2,215	2,107	2,528	2,863
Total Revenue	20,279	19,352	18,657	17,026	16,052
Operating Revenue	20,279	19,352	18,657	17,026	16,052
Total Cost of Revenue	17,682	17,137	16,550	14,498	13,189
Operating Cost of Revenue	17,682	17,137	16,550	14,498	13,189
Total Operating Expenses	3,100	3,912	3,907	3,284	2,772
Selling, General & Admin Expense	2,970	2,948	2,776	2,914	2,773
Other Operating Expenses / (Income)	-29	943	35	106	45
Impairment Charge	0.00	0.00	469	0.00	0.00
Restructuring Charge	159	21	627	264	-46
Total Other Income / (Expense), net	-76	-63	-103	-94	-260
Interest Expense	76	63	103	94	260
Income Tax Expense	364	247	402	524	172
Basic Earnings per Share	($4.21)	($8.96)	($10.28)	($6.06)	($1.48)
Weighted Average Basic Shares Outstanding	224.10M	224.10M	224.10M	226.70M	229.20M
Diluted Earnings per Share	($4.21)	($8.96)	($10.28)	($6.06)	($1.48)
Weighted Average Diluted Shares Outstanding	224.10M	224.10M	224.10M	226.70M	229.20M
Weighted Average Basic & Diluted Shares Outstanding	-	-	224.54M	227.84M	230.51M
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	$0.00	$0.00

This table shows Kyndryl's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-250	-281	-106	-737	-141	-142	-12	-45	11	-43	215
Consolidated Net Income / (Loss)	-250	-281	-106	-737	-141	-142	-12	-45	11	-43	215
Net Income / (Loss) Continuing Operations	-250	-280	-106	-739	-141	-142	-12	-45	11	-43	215
Total Pre-Tax Income	-205	-219	-138	-289	-109	-109	53	-3.00	64	-5.00	258
Total Operating Income	-183	-201	-102	-270	-23	-39	103	89	92	20	299
Total Gross Profit	611	566	707	644	744	651	752	716	805	750	763
Total Revenue	4,288	4,179	4,303	4,256	4,193	4,073	3,936	3,850	3,739	3,774	3,744
Operating Revenue	4,288	4,179	4,303	4,256	4,193	4,073	3,936	3,850	3,739	3,774	3,744
Total Cost of Revenue	3,677	3,613	3,596	3,612	3,449	3,422	3,184	3,134	2,934	3,024	2,981
Operating Cost of Revenue	3,677	3,613	3,596	3,612	3,449	3,422	3,184	3,134	2,934	3,024	2,981
Total Operating Expenses	794	767	809	914	767	690	649	627	713	730	464
Selling, General & Admin Expense	694	706	731	783	720	634	705	714	657	647	647
Other Operating Expenses / (Income)	-3.00	-7.00	30	86	5.00	8.00	21	-28	36	83	-35
Restructuring Charge	103	68	48	45	42	48	-77	-59	20	0.00	-148
Total Other Income / (Expense), net	-24	-19	-37	-14	-87	-70	-50	-92	-28	-25	-41
Interest Expense	24	19	37	14	87	70	50	92	28	25	41
Income Tax Expense	45	61	-32	450	32	33	65	42	53	38	43
Basic Earnings per Share	($1.11)	($1.24)	($0.47)	($3.24)	($0.62)	($0.62)	($0.05)	($0.19)	$0.05	($0.19)	$0.93
Weighted Average Basic Shares Outstanding	225.30M	226.80M	227M	226.70M	227.90M	229.10M	229.60M	229.20M	230.50M	231.60M	232.20M
Diluted Earnings per Share	($1.11)	($1.24)	($0.47)	($3.24)	($0.62)	($0.62)	($0.05)	($0.19)	$0.05	($0.19)	$0.89
Weighted Average Diluted Shares Outstanding	225.30M	226.80M	227M	226.70M	227.90M	229.10M	229.60M	229.20M	235.80M	231.60M	240.70M
Weighted Average Basic & Diluted Shares Outstanding	226.76M	226.79M	227.51M	227.84M	228.89M	229.46M	230.10M	230.51M	231.21M	232.27M	232.69M
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	-	$0.00	$0.00	$0.00	-	$0.00	$0.00	$0.00

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	3/31/2023	3/31/2024
Net Change in Cash & Equivalents	5.00	-13	2,203	-294	-306
Net Cash From Operating Activities	1,134	628	-119	781	454
Net Cash From Continuing Operating Activities	1,133	631	-117	784	454
Net Income / (Loss) Continuing Operations	-943	-2,007	-2,304	-1,374	-340
Consolidated Net Income / (Loss)	-943	-2,007	-2,304	-1,374	-340
Depreciation Expense	1,898	1,869	1,627	1,328	1,153
Amortization Expense	2,137	2,091	1,878	1,717	1,817
Non-Cash Adjustments To Reconcile Net Income	52	68	551	119	138
Changes in Operating Assets and Liabilities, net	-2,011	-1,390	-1,869	-1,006	-2,314
Net Cash From Investing Activities	-1,128	-953	-572	-835	-553
Net Cash From Continuing Investing Activities	-1,129	-953	-572	-835	-553
Purchase of Property, Plant & Equipment	-1,190	-1,036	-752	-865	-651
Sale of Property, Plant & Equipment	63	84	194	23	138
Other Investing Activities, net	-2.00	-1.00	-14	7.00	-40
Net Cash From Financing Activities	0.00	312	2,915	-141	-170
Net Cash From Continuing Financing Activities	0.00	311	2,916	-141	-170
Repayment of Debt	-18	-66	-91	-122	-642
Issuance of Debt	0.00	0.00	3,038	0.00	494
Other Financing Activities, net	18	377	-31	-19	-22
Effect of Exchange Rate Changes	-1.00	-	-22	-100	-37
Cash Interest Paid	0.00	0.00	2.00	98	118
Cash Income Taxes Paid	0.00	0.00	12	167	191

This table details how cash moves in and out of Kyndryl's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-266	13	115	-156	-339	-109	279	-137	-281	57	175
Net Cash From Operating Activities	104	387	278	12	-173	46	436	145	-48	149	260
Net Cash From Continuing Operating Activities	104	389	276	15	-173	46	435	146	-47	148	259
Net Income / (Loss) Continuing Operations	-250	-281	-106	-737	-141	-142	-12	-45	11	-43	215
Consolidated Net Income / (Loss)	-250	-281	-106	-737	-141	-142	-12	-45	11	-43	215
Depreciation Expense	313	327	326	362	301	303	286	263	197	233	261
Amortization Expense	418	413	451	435	471	456	460	430	424	445	442
Non-Cash Adjustments To Reconcile Net Income	28	47	-11	55	51	19	-4.00	72	51	-16	-65
Changes in Operating Assets and Liabilities, net	-405	-117	-384	-100	-855	-590	-295	-574	-730	-471	-594
Net Cash From Investing Activities	-218	-298	-183	-136	-113	-95	-142	-203	-166	-75	42
Net Cash From Continuing Investing Activities	-219	-297	-183	-136	-113	-96	-141	-203	-166	-75	41
Purchase of Property, Plant & Equipment	-213	-253	-245	-154	-100	-175	-174	-202	-122	-134	-109
Sale of Property, Plant & Equipment	7.00	3.00	10	3.00	6.00	113	15	4.00	24	30	16
Other Investing Activities, net	-13	-47	52	15	-19	-34	18	-5.00	-22	29	88
Net Cash From Financing Activities	-41	-28	-31	-41	-38	-42	-43	-47	-51	-50	-71
Net Cash From Continuing Financing Activities	-41	-28	-31	-41	-38	-42	-43	-47	-51	-51	-70
Repayment of Debt	-28	-28	-27	-39	-31	-37	-36	-538	-44	-34	-32
Other Financing Activities, net	-13	-	-4.00	-2.00	-7.00	-5.00	-7.00	-3.00	-7.00	-17	-8.00
Effect of Exchange Rate Changes	-111	-49	51	9.00	-15	-18	28	-32	-17	34	-56
Cash Interest Paid	38	-4.00	55	9.00	46	13	49	10	40	20	40
Cash Income Taxes Paid	8.00	29	72	58	65	23	52	51	54	35	34

This table presents Kyndryl's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2022	2023	2024
Period end date	12/31/2020	3/31/2022	3/31/2023	3/31/2024
Total Assets	11,205	13,442	11,464	10,590
Total Current Assets	2,843	6,092	4,963	4,747
Cash & Equivalents	24	2,134	1,847	1,553
Restricted Cash	14	20	12	1.00
Accounts Receivable	1,444	2,271	1,523	1,599
Prepaid Expenses	157	525	510	514
Other Current Assets	1,205	1,143	1,070	1,081
Plant, Property, & Equipment, net	3,991	2,834	2,779	2,674
Total Noncurrent Assets	4,372	4,515	3,722	3,169
Goodwill	1,230	823	812	805
Intangible Assets	60	145	171	188
Noncurrent Deferred & Refundable Income Taxes	424	555	248	220
Employee Benefit Assets	1.00	61	94	105
Other Noncurrent Operating Assets	2,657	2,931	2,397	1,851
Total Liabilities & Shareholders' Equity	11,205	13,442	11,464	10,590
Total Liabilities	6,274	10,730	10,002	9,468
Total Current Liabilities	3,910	5,058	4,868	4,589
Short-Term Debt	69	96	110	126
Accounts Payable	919	1,555	1,774	1,408
Accrued Expenses	1,386	1,358	970	1,008
Current Deferred Revenue	854	882	820	825
Current Deferred & Payable Income Tax Liabilities	0.00	-	-	327
Current Employee Benefit Liabilities	350	509	533	609
Other Current Liabilities	333	374	316	285
Total Noncurrent Liabilities	2,365	5,672	5,134	4,880
Long-Term Debt	140	3,127	3,111	3,112
Noncurrent Deferred Revenue	543	452	362	314
Noncurrent Employee Benefit Liabilities	550	716	504	500
Other Noncurrent Operating Liabilities	1,132	1,377	1,157	954
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,931	2,711	1,462	1,122
Total Preferred & Common Equity	4,873	2,618	1,365	1,015
Total Common Equity	4,872	2,617	1,365	1,015
Common Stock	0.00	4,315	4,428	4,524
Retained Earnings	0.00	-605	-1,978	-2,319
Treasury Stock	0.00	-4.00	-23	-45
Accumulated Other Comprehensive Income / (Loss)	-1,100	-1,089	-1,062	-1,145
Noncontrolling Interest	58	94	97	107

This table presents Kyndryl's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	12/31/2021	6/30/2022	9/30/2022	12/31/2022	6/30/2023	9/30/2023	12/31/2023	6/30/2024	9/30/2024	12/31/2024
Total Assets	13,213	12,304	11,629	11,851	10,986	10,602	10,969	10,163	10,396	9,925
Total Current Assets	5,777	5,404	4,964	4,967	4,653	4,593	4,851	4,355	4,387	4,297
Cash & Equivalents	2,223	1,871	1,888	2,002	1,507	1,408	1,688	1,269	1,325	1,501
Restricted Cash	17	17	12	14	14	3.00	2.00	5.00	5.00	5.00
Accounts Receivable	2,279	1,902	1,578	1,539	1,490	1,663	1,658	1,440	1,441	1,374
Prepaid Expenses	337	522	512	486	567	566	578	613	623	529
Other Current Assets	920	1,092	973	927	1,075	952	924	1,029	994	889
Plant, Property, & Equipment, net	2,923	2,651	2,592	2,762	2,750	2,646	2,806	2,690	2,735	2,490
Total Noncurrent Assets	4,512	4,250	4,072	4,122	3,583	3,364	3,313	3,117	3,273	3,140
Goodwill	732	815	811	812	807	806	809	786	790	787
Intangible Assets	36	154	139	158	187	188	192	222	227	219
Noncurrent Deferred & Refundable Income Taxes	675	525	481	478	190	186	208	207	209	184
Employee Benefit Assets	58	58	54	58	100	97	105	109	123	130
Other Noncurrent Operating Assets	3,011	2,698	2,587	2,616	2,299	2,087	1,999	1,793	1,924	1,820
Total Liabilities & Shareholders' Equity	13,213	12,304	11,629	11,851	10,986	10,602	10,969	10,163	10,396	9,925
Total Liabilities	10,446	10,093	9,882	9,920	9,648	9,489	9,676	9,062	9,224	8,721
Total Current Liabilities	4,457	4,609	4,579	4,607	4,591	4,485	5,152	4,231	4,249	3,935
Short-Term Debt	105	93	97	103	134	121	628	130	135	129
Accounts Payable	1,140	1,486	1,594	1,719	1,626	1,246	1,477	1,337	1,240	1,147
Accrued Expenses	1,242	1,129	1,042	1,006	907	1,137	1,107	969	904	867
Current Deferred Revenue	872	774	726	817	785	790	793	805	856	782
Current Deferred & Payable Income Tax Liabilities	357	274	-	245	359	-	332	-	-	259
Current Employee Benefit Liabilities	381	503	534	388	473	609	559	414	538	492
Other Current Liabilities	360	350	322	329	307	274	257	271	278	259
Total Noncurrent Liabilities	5,988	5,485	5,303	5,313	5,057	5,003	4,523	4,830	4,975	4,786
Long-Term Debt	3,128	3,107	3,101	3,097	3,149	3,123	2,629	3,109	3,106	3,072
Noncurrent Deferred Revenue	475	413	373	377	334	316	326	325	344	328
Noncurrent Employee Benefit Liabilities	856	671	625	660	501	481	493	492	510	475
Other Noncurrent Operating Liabilities	1,529	1,294	1,204	1,179	1,073	1,083	1,075	904	1,015	911
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,767	2,211	1,746	1,930	1,338	1,113	1,293	1,101	1,172	1,204
Total Preferred & Common Equity	2,765	2,117	1,650	1,832	1,240	1,013	1,189	996	1,065	1,094
Total Common Equity	2,765	2,116	1,650	1,832	1,239	1,012	1,190	996	1,065	1,094
Common Stock	4,284	4,341	4,370	4,397	4,451	4,476	4,501	4,549	4,575	4,607
Retained Earnings	-375	-855	-1,136	-1,241	-2,120	-2,262	-2,274	-2,308	-2,351	-2,136
Treasury Stock	-1.00	-17	-17	-21	-30	-35	-42	-53	-69	-107
Accumulated Other Comprehensive Income / (Loss)	-1,143	-1,353	-1,567	-1,303	-1,062	-1,167	-995	-1,192	-1,090	-1,270
Noncontrolling Interest	3.00	95	96	99	99	100	104	105	107	110

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2021	3/31/2023	3/31/2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	-4.57%	-3.59%	0.00%	-8.74%	-5.72%
EBITDA Growth	0.00%	-35.93%	-24.66%	0.00%	34.25%	33.73%
EBIT Growth	0.00%	-237.38%	-6.07%	0.00%	58.00%	112.04%
NOPAT Growth	0.00%	-237.38%	-6.07%	0.00%	58.00%	112.04%
Net Income Growth	0.00%	-112.83%	-14.80%	0.00%	40.36%	75.25%
EPS Growth	0.00%	-112.83%	-14.73%	0.00%	41.05%	75.58%
Operating Cash Flow Growth	0.00%	-44.62%	-118.95%	0.00%	756.30%	-41.87%
Free Cash Flow Firm Growth	0.00%	0.00%	101.32%	-1,644.58%	133.60%	-81.96%
Invested Capital Growth	0.00%	0.00%	-26.32%	0.59%	-25.39%	-0.50%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-2.94%	-2.47%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-2.14%	9.09%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	9.68%	133.96%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	9.68%	133.96%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-21.49%	67.05%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-20.72%	67.33%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	71.67%	-114.60%	77.10%	41.43%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	13.60%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-9.47%	-1.85%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	12.81%	11.45%	11.29%	11.29%	14.85%	17.84%
EBITDA Margin	17.42%	11.69%	9.14%	9.14%	13.44%	19.07%
Operating Margin	-2.48%	-8.77%	-9.65%	-9.65%	-4.44%	0.57%
EBIT Margin	-2.48%	-8.77%	-9.65%	-9.65%	-4.44%	0.57%
Profit (Net Income) Margin	-4.65%	-10.37%	-12.35%	-12.35%	-8.07%	-2.12%
Tax Burden Percent	162.87%	114.03%	121.07%	121.07%	161.46%	202.38%
Interest Burden Percent	115.11%	103.71%	105.72%	105.72%	112.57%	-184.62%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-46.57%	-28.44%	-33.42%	-16.03%	2.26%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-1,004.58%	-207.97%	-134.68%	-85.59%	-24.26%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-34.84%	-31.42%	-53.16%	-49.82%	-28.58%
Return on Equity (ROE)	0.00%	-81.40%	-59.86%	-86.58%	-65.85%	-26.32%
Cash Return on Invested Capital (CROIC)	0.00%	-246.57%	1.87%	-34.01%	13.05%	2.76%
Operating Return on Assets (OROA)	0.00%	-15.15%	-14.74%	-13.39%	-6.07%	0.83%
Return on Assets (ROA)	0.00%	-17.91%	-18.87%	-17.14%	-11.03%	-3.08%
Return on Common Equity (ROCE)	0.00%	-80.43%	-59.39%	-83.58%	-62.84%	-24.24%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-41.19%	-83.33%	-88.01%	-100.66%	-33.50%
Net Operating Profit after Tax (NOPAT)	-352	-1,188	-1,260	-1,260	-529	64
NOPAT Margin	-1.74%	-6.14%	-6.75%	-6.75%	-3.11%	0.40%
Net Nonoperating Expense Percent (NNEP)	0.00%	958.01%	179.54%	101.26%	69.56%	26.52%
Cost of Revenue to Revenue	87.19%	88.55%	88.71%	88.71%	85.15%	82.16%
SG&A Expenses to Revenue	14.65%	15.23%	14.88%	14.88%	17.12%	17.28%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.29%	20.22%	20.94%	20.94%	19.29%	17.27%
Earnings before Interest and Taxes (EBIT)	-503	-1,697	-1,800	-1,800	-756	91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,532	2,263	1,705	1,705	2,289	3,061
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	1.47	1.55	2.46	4.93
Price to Tangible Book Value (P/TBV)	0.00	0.00	2.03	2.46	8.79	227.59
Price to Revenue (P/Rev)	0.00	0.00	0.22	0.22	0.20	0.31
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.34	1.38	1.71	2.42
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.27	0.28	0.28	0.42
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	2.96	3.06	2.10	2.22
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	74.70
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	106.72
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	6.17	14.97
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	60.87	0.00	11.18	87.49
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.04	1.17	1.19	2.20	2.89
Long-Term Debt to Equity	0.00	0.03	1.13	1.15	2.13	2.77
Financial Leverage	0.00	0.03	0.15	0.39	0.58	1.18
Leverage Ratio	0.00	2.27	3.17	4.96	5.97	8.53
Compound Leverage Factor	0.00	2.36	3.35	5.24	6.72	-15.76
Debt to Total Capital	0.00%	4.07%	53.88%	54.31%	68.78%	74.27%
Short-Term Debt to Total Capital	0.00%	1.34%	1.75%	1.62%	2.35%	2.89%
Long-Term Debt to Total Capital	0.00%	2.72%	52.13%	52.70%	66.43%	71.38%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	1.13%	0.05%	1.58%	2.07%	2.45%
Common Equity to Total Capital	0.00%	94.79%	46.08%	44.10%	29.15%	23.28%
Debt to EBITDA	0.00	0.09	1.90	1.89	1.41	1.06
Net Debt to EBITDA	0.00	0.08	0.58	0.63	0.60	0.55
Long-Term Debt to EBITDA	0.00	0.06	1.83	1.83	1.36	1.02
Debt to NOPAT	0.00	-0.18	-2.57	-2.56	-6.09	50.83
Net Debt to NOPAT	0.00	-0.14	-0.79	-0.85	-2.57	26.44
Long-Term Debt to NOPAT	0.00	-0.12	-2.48	-2.48	-5.88	48.85
Altman Z-Score	0.00	0.00	1.28	1.20	1.24	1.57
Noncontrolling Interest Sharing Ratio	0.00%	1.20%	0.79%	3.47%	4.58%	7.89%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	0.73	1.30	1.20	1.02	1.03
Quick Ratio	0.00	0.38	1.01	0.87	0.69	0.69
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-6,290	83	-1,282	431	78
Operating Cash Flow to CapEx	100.62%	65.97%	-21.33%	-21.33%	92.76%	88.50%
Free Cash Flow to Firm to Interest Expense	0.00	-99.84	0.81	-12.45	4.58	0.30
Operating Cash Flow to Interest Expense	14.92	9.97	-1.16	-1.16	8.31	1.75
Operating Cash Flow Less CapEx to Interest Expense	0.09	-5.14	-6.57	-6.57	-0.65	-0.23
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	1.73	1.53	1.39	1.37	1.46
Accounts Receivable Turnover	0.00	13.40	10.02	8.22	8.98	10.28
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	4.85	5.40	6.58	6.07	5.89
Accounts Payable Turnover	0.00	18.65	16.08	10.64	8.71	8.29
Days Sales Outstanding (DSO)	0.00	27.24	36.42	44.43	40.67	35.50
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	19.57	22.71	34.29	41.91	44.03
Cash Conversion Cycle (CCC)	0.00	7.66	13.71	10.13	-1.24	-8.54
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	5,102	3,759	3,781	2,821	2,807
Invested Capital Turnover	0.00	7.59	4.21	4.95	5.16	5.70
Increase / (Decrease) in Invested Capital	0.00	5,102	-1,343	22	-960	-14
Enterprise Value (EV)	0.00	0.00	5,052	5,220	4,817	6,798
Market Capitalization	0.00	0.00	4,056	4,057	3,358	5,007
Book Value per Share	$0.00	$21.74	$12.34	$11.68	$6.00	$4.41
Tangible Book Value per Share	$0.00	$15.98	$8.91	$7.36	$1.68	$0.10
Total Capital	0.00	5,140	6,000	5,934	4,683	4,360
Total Debt	0.00	209	3,233	3,223	3,221	3,238
Total Long-Term Debt	0.00	140	3,128	3,127	3,111	3,112
Net Debt	0.00	171	993	1,069	1,362	1,684
Capital Expenditures (CapEx)	1,127	952	558	558	842	513
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-1,036	-815	-1,024	-1,654	-1,270
Debt-free Net Working Capital (DFNWC)	0.00	-998	1,425	1,130	205	284
Net Working Capital (NWC)	0.00	-1,067	1,320	1,034	95	158
Net Nonoperating Expense (NNE)	591	819	1,044	1,044	845	404
Net Nonoperating Obligations (NNO)	0.00	171	992	1,070	1,359	1,685
Total Depreciation and Amortization (D&A)	4,035	3,960	3,505	3,505	3,045	2,970
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-5.35%	-4.37%	-5.49%	-9.71%	-7.91%
Debt-free Net Working Capital to Revenue	0.00%	-5.16%	7.64%	6.06%	1.20%	1.77%
Net Working Capital to Revenue	0.00%	-5.51%	7.08%	5.54%	0.56%	0.98%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($10.35)	($10.35)	($6.06)	($1.48)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	224.10M	224.10M	226.70M	229.20M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($10.35)	($10.35)	($6.06)	($1.48)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	224.10M	224.10M	226.70M	229.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	224.54M	224.54M	227.84M	230.51M
Normalized Net Operating Profit after Tax (NOPAT)	-241	-1,173	-493	-493	-344	32
Normalized NOPAT Margin	-1.19%	-6.06%	-2.64%	-2.64%	-2.02%	0.20%
Pre Tax Income Margin	-2.86%	-9.09%	-10.20%	-10.20%	-5.00%	-1.05%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-6.62	-26.94	-17.48	-17.48	-8.04	0.35
NOPAT to Interest Expense	-4.63	-18.86	-12.23	-12.23	-5.63	0.25
EBIT Less CapEx to Interest Expense	-21.45	-42.05	-22.89	-22.89	-17.00	-1.62
NOPAT Less CapEx to Interest Expense	-19.46	-33.97	-17.65	-17.65	-14.59	-1.73
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Kyndryl's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.75%	-8.74%	-5.55%	-10.79%	-2.22%	-2.54%	-8.53%	-9.54%	-10.83%	-7.34%	-4.88%
EBITDA Growth	-12.18%	35.77%	530.84%	-8.67%	36.68%	33.58%	25.78%	48.39%	-4.81%	-3.06%	18.02%
EBIT Growth	38.59%	55.23%	85.47%	23.08%	87.43%	80.60%	200.98%	132.96%	500.00%	151.28%	190.29%
NOPAT Growth	38.59%	55.23%	85.47%	23.08%	87.43%	80.60%	67.34%	132.96%	198.21%	151.28%	1,168.43%
Net Income Growth	35.73%	59.28%	85.50%	-49.19%	43.60%	49.47%	88.68%	93.89%	107.80%	69.72%	1,891.67%
EPS Growth	36.21%	59.74%	85.58%	-47.27%	44.14%	50.00%	89.36%	94.14%	108.06%	69.35%	1,880.00%
Operating Cash Flow Growth	164.60%	263.98%	-54.13%	103.66%	-266.35%	-88.11%	56.83%	1,108.33%	72.25%	223.91%	-40.37%
Free Cash Flow Firm Growth	0.00%	0.00%	-34.34%	0.00%	111.14%	102.16%	-59.29%	-90.10%	-88.25%	-277.58%	-10.96%
Invested Capital Growth	0.00%	0.00%	-17.11%	-25.39%	-12.01%	-3.15%	-8.22%	-0.50%	-1.03%	4.61%	1.47%
Revenue Q/Q Growth	-10.12%	-2.54%	2.97%	-1.09%	-1.48%	-2.86%	-3.36%	-2.19%	-2.88%	0.94%	-0.79%
EBITDA Q/Q Growth	-5.03%	-1.64%	25.23%	-21.93%	42.13%	-3.87%	17.92%	-7.89%	-8.82%	-2.10%	43.55%
EBIT Q/Q Growth	47.86%	-9.84%	49.25%	-164.71%	91.48%	-69.57%	364.10%	-13.59%	3.37%	-78.26%	1,395.00%
NOPAT Q/Q Growth	47.86%	-9.84%	49.25%	-164.71%	91.48%	-69.57%	14.58%	367.14%	-74.62%	-11.46%	1,679.76%
Net Income Q/Q Growth	49.39%	-12.40%	62.28%	-595.28%	80.87%	-0.71%	91.55%	-275.00%	124.44%	-490.91%	600.00%
EPS Q/Q Growth	49.55%	-11.71%	62.10%	-589.36%	80.86%	0.00%	91.94%	-280.00%	126.32%	-480.00%	568.42%
Operating Cash Flow Q/Q Growth	131.71%	272.12%	-28.17%	-95.68%	-1,541.67%	126.59%	847.83%	-66.74%	-133.10%	410.42%	74.50%
Free Cash Flow Firm Q/Q Growth	0.00%	12.80%	117.95%	34.88%	-47.22%	-83.12%	238.69%	-67.21%	-37.34%	-355.16%	269.81%
Invested Capital Q/Q Growth	-6.82%	-13.62%	2.40%	-9.47%	9.89%	-4.94%	-2.95%	-1.85%	9.30%	0.49%	-5.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.25%	13.54%	16.43%	15.13%	17.74%	15.98%	19.11%	18.60%	21.53%	19.87%	20.38%
EBITDA Margin	12.78%	12.90%	15.69%	12.38%	17.86%	17.68%	21.57%	20.31%	19.07%	18.50%	26.76%
Operating Margin	-4.27%	-4.81%	-2.37%	-6.34%	-0.55%	-0.96%	2.62%	2.31%	2.46%	0.53%	7.99%
EBIT Margin	-4.27%	-4.81%	-2.37%	-6.34%	-0.55%	-0.96%	2.62%	2.31%	2.46%	0.53%	7.99%
Profit (Net Income) Margin	-5.83%	-6.72%	-2.46%	-17.32%	-3.36%	-3.49%	-0.30%	-1.17%	0.29%	-1.14%	5.74%
Tax Burden Percent	121.95%	128.31%	76.81%	255.02%	129.36%	130.28%	-22.64%	1,500.00%	17.19%	860.00%	83.33%
Interest Burden Percent	112.02%	108.96%	135.29%	107.04%	473.91%	279.49%	51.46%	-3.37%	69.57%	-25.00%	86.29%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	122.64%	0.00%	82.81%	0.00%	16.67%
Return on Invested Capital (ROIC)	-30.86%	-39.38%	-8.47%	-22.90%	-1.96%	-3.77%	-3.26%	9.23%	2.14%	1.88%	34.90%
ROIC Less NNEP Spread (ROIC-NNEP)	-49.44%	-61.01%	-11.64%	-68.03%	-10.09%	-11.09%	-2.44%	2.18%	1.88%	-1.16%	32.80%
Return on Net Nonoperating Assets (RNNOA)	-29.34%	-45.32%	-5.40%	-39.60%	-8.74%	-12.15%	-2.09%	2.57%	2.88%	-1.90%	42.89%
Return on Equity (ROE)	-60.19%	-84.70%	-13.87%	-62.50%	-10.70%	-15.91%	-5.35%	11.80%	5.01%	-0.02%	77.79%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	13.05%	0.18%	-6.94%	3.20%	2.76%	-250.12%	-11.69%	5.57%
Operating Return on Assets (OROA)	-6.31%	-7.36%	-3.32%	-8.67%	-0.80%	-1.45%	3.77%	3.37%	3.63%	0.77%	11.55%
Return on Assets (ROA)	-8.62%	-10.29%	-3.45%	-23.68%	-4.89%	-5.28%	-0.44%	-1.70%	0.43%	-1.66%	8.30%
Return on Common Equity (ROCE)	-57.61%	-80.04%	-13.57%	-59.64%	-10.12%	-14.82%	-5.02%	10.87%	4.60%	-0.02%	71.16%
Return on Equity Simple (ROE_SIMPLE)	-102.27%	-106.42%	-61.74%	0.00%	-102.02%	-111.16%	-86.80%	0.00%	-18.88%	-8.36%	12.61%
Net Operating Profit after Tax (NOPAT)	-128	-141	-71	-189	-16	-27	-23	62	16	14	249
NOPAT Margin	-2.99%	-3.37%	-1.66%	-4.44%	-0.38%	-0.67%	-0.59%	1.62%	0.42%	0.37%	6.66%
Net Nonoperating Expense Percent (NNEP)	18.58%	21.63%	3.18%	45.12%	8.13%	7.33%	-0.82%	7.05%	0.26%	3.04%	2.09%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-0.51%	-	-	-	5.66%
Cost of Revenue to Revenue	85.75%	86.46%	83.57%	84.87%	82.26%	84.02%	80.89%	81.40%	78.47%	80.13%	79.62%
SG&A Expenses to Revenue	16.18%	16.89%	16.99%	18.40%	17.17%	15.57%	17.91%	18.55%	17.57%	17.14%	17.28%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.52%	18.35%	18.80%	21.48%	18.29%	16.94%	16.49%	16.29%	19.07%	19.34%	12.39%
Earnings before Interest and Taxes (EBIT)	-183	-201	-102	-270	-23	-39	103	89	92	20	299
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	548	539	675	527	749	720	849	782	713	698	1,002
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.04	1.14	1.38	2.46	2.44	3.42	4.01	4.93	6.09	4.99	7.35
Price to Tangible Book Value (P/TBV)	1.91	2.68	2.93	8.79	12.35	192.02	25.23	227.59	0.00	110.69	91.32
Price to Revenue (P/Rev)	0.12	0.11	0.14	0.20	0.18	0.21	0.29	0.31	0.39	0.35	0.53
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	58.24
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.72%
Enterprise Value to Invested Capital (EV/IC)	1.02	1.07	1.22	1.71	1.58	1.83	2.25	2.42	2.65	2.38	3.39
Enterprise Value to Revenue (EV/Rev)	0.20	0.18	0.22	0.28	0.29	0.32	0.39	0.42	0.52	0.48	0.65
Enterprise Value to EBITDA (EV/EBITDA)	2.21	1.85	1.63	2.10	1.96	2.02	2.26	2.22	2.69	2.44	3.12
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	74.70	39.49	27.66	21.35
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	106.72	0.00	0.00	48.58
Enterprise Value to Operating Cash Flow (EV/OCF)	24.68	4.25	8.63	6.17	9.70	33.06	20.06	14.97	14.05	10.75	19.45
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	11.18	842.55	0.00	67.29	87.49	0.00	0.00	61.28
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.45	1.83	1.66	2.20	2.45	2.91	2.52	2.89	2.94	2.77	2.66
Long-Term Debt to Equity	1.41	1.78	1.60	2.13	2.35	2.81	2.03	2.77	2.82	2.65	2.55
Financial Leverage	0.59	0.74	0.46	0.58	0.87	1.10	0.85	1.18	1.53	1.64	1.31
Leverage Ratio	5.56	6.66	5.34	5.97	6.56	7.78	7.08	8.53	8.67	9.19	8.37
Compound Leverage Factor	6.23	7.26	7.22	6.39	31.10	21.73	3.64	-0.29	6.03	-2.30	7.22
Debt to Total Capital	59.14%	64.68%	62.38%	68.78%	71.05%	74.45%	71.58%	74.27%	74.63%	73.44%	72.67%
Short-Term Debt to Total Capital	1.72%	1.96%	2.01%	2.35%	2.90%	2.78%	13.80%	2.89%	3.00%	3.06%	2.93%
Long-Term Debt to Total Capital	57.42%	62.72%	60.37%	66.43%	68.15%	71.68%	57.78%	71.38%	71.64%	70.38%	69.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.76%	1.94%	1.93%	2.07%	2.14%	2.30%	2.29%	2.45%	2.42%	2.42%	2.50%
Common Equity to Total Capital	39.11%	33.37%	35.71%	29.15%	26.81%	23.23%	26.15%	23.28%	22.95%	24.13%	24.84%
Debt to EBITDA	1.96	1.81	1.37	1.41	1.32	1.21	1.14	1.06	1.07	1.08	1.01
Net Debt to EBITDA	0.81	0.73	0.51	0.60	0.71	0.69	0.55	0.55	0.65	0.64	0.54
Long-Term Debt to EBITDA	1.91	1.75	1.32	1.36	1.26	1.17	0.92	1.02	1.03	1.03	0.97
Debt to NOPAT	-2.71	-3.18	-5.46	-6.09	-7.87	-10.68	-20.32	50.83	-0.42	-14.98	15.80
Net Debt to NOPAT	-1.11	-1.29	-2.02	-2.57	-4.22	-6.03	-9.78	26.44	-0.25	-8.83	8.37
Long-Term Debt to NOPAT	-2.63	-3.08	-5.29	-5.88	-7.55	-10.28	-16.40	48.85	-0.40	-14.35	15.16
Altman Z-Score	1.54	1.49	1.49	1.38	1.46	1.51	1.50	1.57	1.66	1.52	1.92
Noncontrolling Interest Sharing Ratio	4.30%	5.50%	2.13%	4.58%	5.47%	6.89%	6.24%	7.89%	8.36%	9.10%	8.53%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.17	1.08	1.08	1.02	1.01	1.02	0.94	1.03	1.03	1.03	1.09
Quick Ratio	0.82	0.76	0.77	0.69	0.65	0.68	0.65	0.69	0.64	0.65	0.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,651	-3,184	572	771	407	69	233	76	48	-122	207
Operating Cash Flow to CapEx	50.49%	154.80%	118.30%	7.95%	-184.04%	74.19%	274.21%	73.23%	-48.98%	143.27%	279.57%
Free Cash Flow to Firm to Interest Expense	-152.13	-167.56	15.45	55.07	4.68	0.98	4.65	0.83	1.71	-4.88	5.05
Operating Cash Flow to Interest Expense	4.33	20.37	7.51	0.86	-1.99	0.66	8.72	1.58	-1.71	5.96	6.34
Operating Cash Flow Less CapEx to Interest Expense	-4.25	7.21	1.16	-9.93	-3.07	-0.23	5.54	-0.58	-5.21	1.80	4.07
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.48	1.53	1.40	1.37	1.45	1.51	1.44	1.46	1.48	1.46	1.45
Accounts Receivable Turnover	9.57	11.28	9.19	8.98	9.98	10.38	10.30	10.28	10.65	9.86	9.97
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	6.86	6.87	6.17	6.07	6.27	6.42	5.91	5.89	5.73	5.69	5.71
Accounts Payable Turnover	10.81	9.79	10.64	8.71	9.17	9.91	8.55	8.29	8.55	9.88	9.20
Days Sales Outstanding (DSO)	38.16	32.37	39.72	40.67	36.56	35.16	35.45	35.50	34.28	37.03	36.63
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	33.76	37.28	34.32	41.91	39.80	36.81	42.68	44.03	42.67	36.96	39.67
Cash Conversion Cycle (CCC)	4.39	-4.91	5.41	-1.24	-3.24	-1.66	-7.23	-8.54	-8.38	0.07	-3.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,523	3,043	3,116	2,821	3,100	2,947	2,860	2,807	3,068	3,083	2,902
Invested Capital Turnover	10.33	11.70	5.10	5.16	5.11	5.62	5.51	5.70	5.06	5.07	5.24
Increase / (Decrease) in Invested Capital	3,523	3,043	-643	-960	-423	-96	-256	-14	-32	136	42
Enterprise Value (EV)	3,603	3,269	3,805	4,817	4,887	5,389	6,439	6,798	8,135	7,331	9,842
Market Capitalization	2,196	1,875	2,522	3,358	3,026	3,456	4,768	5,007	6,065	5,313	8,037
Book Value per Share	$9.42	$7.28	$8.08	$6.00	$5.44	$4.42	$5.19	$4.41	$4.32	$4.61	$4.71
Tangible Book Value per Share	$5.11	$3.09	$3.80	$1.68	$1.08	$0.08	$0.82	$0.10	($0.05)	$0.21	$0.38
Total Capital	5,411	4,944	5,130	4,683	4,621	4,357	4,550	4,360	4,340	4,413	4,405
Total Debt	3,200	3,198	3,200	3,221	3,283	3,244	3,257	3,238	3,239	3,241	3,201
Total Long-Term Debt	3,107	3,101	3,097	3,111	3,149	3,123	2,629	3,112	3,109	3,106	3,072
Net Debt	1,312	1,298	1,184	1,362	1,762	1,833	1,567	1,684	1,965	1,911	1,695
Capital Expenditures (CapEx)	206	250	235	151	94	62	159	198	98	104	93
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,000	-1,418	-1,553	-1,654	-1,325	-1,182	-1,363	-1,270	-1,020	-1,057	-1,015
Debt-free Net Working Capital (DFNWC)	888	482	463	205	196	229	327	284	254	273	491
Net Working Capital (NWC)	795	385	360	95	62	108	-301	158	124	138	362
Net Nonoperating Expense (NNE)	122	140	35	548	125	115	-11	107	4.81	57	34
Net Nonoperating Obligations (NNO)	1,312	1,297	1,186	1,359	1,762	1,834	1,567	1,685	1,967	1,911	1,698
Total Depreciation and Amortization (D&A)	731	740	777	797	772	759	746	693	621	678	703
Debt-free, Cash-free Net Working Capital to Revenue	-5.50%	-7.97%	-8.85%	-9.71%	-7.83%	-7.03%	-8.28%	-7.91%	-6.54%	-6.91%	-6.72%
Debt-free Net Working Capital to Revenue	4.88%	2.71%	2.64%	1.20%	1.16%	1.36%	1.99%	1.77%	1.63%	1.78%	3.25%
Net Working Capital to Revenue	4.37%	2.16%	2.05%	0.56%	0.37%	0.64%	-1.83%	0.98%	0.80%	0.90%	2.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.11)	($1.24)	($0.47)	($3.24)	($0.62)	($0.62)	($0.05)	($0.19)	$0.05	($0.19)	$0.93
Adjusted Weighted Average Basic Shares Outstanding	225.30M	226.80M	227M	226.70M	227.90M	229.10M	229.60M	229.20M	230.50M	231.60M	232.20M
Adjusted Diluted Earnings per Share	($1.11)	($1.24)	($0.47)	($3.24)	($0.62)	($0.62)	($0.05)	($0.19)	$0.05	($0.19)	$0.89
Adjusted Weighted Average Diluted Shares Outstanding	225.30M	226.80M	227M	226.70M	227.90M	229.10M	229.60M	229.20M	235.80M	231.60M	240.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	226.76M	226.79M	227.51M	227.84M	228.89M	229.46M	230.10M	230.51M	231.21M	232.27M	232.69M
Normalized Net Operating Profit after Tax (NOPAT)	-56	-93	-38	-158	13	6.30	18	21	78	14	126
Normalized NOPAT Margin	-1.31%	-2.23%	-0.88%	-3.70%	0.32%	0.15%	0.46%	0.55%	2.10%	0.37%	3.36%
Pre Tax Income Margin	-4.78%	-5.24%	-3.21%	-6.79%	-2.60%	-2.68%	1.35%	-0.08%	1.71%	-0.13%	6.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-7.63	-10.58	-2.76	-19.29	-0.26	-0.56	2.06	0.97	3.29	0.80	7.29
NOPAT to Interest Expense	-5.34	-7.41	-1.93	-13.50	-0.19	-0.39	-0.47	0.68	0.56	0.56	6.08
EBIT Less CapEx to Interest Expense	-16.21	-23.74	-9.11	-30.07	-1.34	-1.44	-1.12	-1.18	-0.21	-3.36	5.02
NOPAT Less CapEx to Interest Expense	-13.92	-20.56	-8.28	-24.29	-1.27	-1.28	-3.65	-1.48	-2.94	-3.60	3.81
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Kyndryl's Financials

When does Kyndryl's financial year end?

According to the most recent income statement we have on file, Kyndryl's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has Kyndryl's net income changed over the last 4 years?

Kyndryl's net income appears to be on a downward trend, with a most recent value of -$340 million in 2024, falling from -$943 million in 2019. The previous period was -$1.37 billion in 2023. Find out what analysts predict for Kyndryl in the coming months.

What is Kyndryl's operating income?

Kyndryl's total operating income in 2024 was $91 million, based on the following breakdown:

Total Gross Profit: $2.86 billion
Total Operating Expenses: $2.77 billion

How has Kyndryl revenue changed over the last 4 years?

Over the last 4 years, Kyndryl's total revenue changed from $20.28 billion in 2019 to $16.05 billion in 2024, a change of -20.8%.

How much debt does Kyndryl have?

Kyndryl's total liabilities were at $9.47 billion at the end of 2024, a 5.3% decrease from 2023, and a 50.9% increase since 2020.

How much cash does Kyndryl have?

In the past 3 years, Kyndryl's cash and equivalents has ranged from $24 million in 2020 to $2.13 billion in 2022, and is currently $1.55 billion as of their latest financial filing in 2024.

How has Kyndryl's book value per share changed over the last 5 years?

Over the last 5 years, Kyndryl's book value per share changed from 0.00 in 2019 to 4.41 in 2024, a change of 441.1%.

Related Companies

This page (NYSE:KD) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kyndryl (KD) Financials

Frequently Asked Questions About Kyndryl's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kyndryl (KD) Financials

Annual Income Statements for Kyndryl

Quarterly Income Statements for Kyndryl

Annual Cash Flow Statements for Kyndryl

Quarterly Cash Flow Statements for Kyndryl

Annual Balance Sheets for Kyndryl

Quarterly Balance Sheets for Kyndryl

Annual Metrics and Ratios for Kyndryl

Quarterly Metrics and Ratios for Kyndryl

Frequently Asked Questions About Kyndryl's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools